col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


389 Results       Page 1

 [1] 
Elsevier: Journal of the American Academy of Dermatology
  original article Date Title Authors   All Authors
1 [GO] 2024―Jan―21 Asynchronous Direct-to-Patient Teledermatology Visits (E-visits) during COVID-19 Pandemic: Lessons for future teledermatology practice. Nicole Trupiano, Rebecca H. Goldberg, Madison Novice, Jianheng Mai, Haihan Zhang, Sruthi Renati, et al. (+2)
2 [GO] 2023―Nov―19 COVID-19 pandemic-related decreases in HFMD and Scabies: A retrospective study Ania Stolarczyk, Julie Ryan Wolf, Alice Pentland
3 [GO] 2023―Sep―28 Evaluating the Role of COVID-19 Vaccines in the Landscape of Medication-induced Alopecia Areata Michael G. Buontempo, Lina Alhanshali, Jerry Shapiro, Kristen Lo Sicco
4 [GO] 2023―Sep―25 44305 Impact of rurality and insurance type on delays in melanoma diagnosis during COVID-19 Ananya Munjal, Madeline Fitzhugh, Smrithi Mani, Madalyn Walsh, Pavane Gorrepati, Raghav Tripathi, et al. (+2)
5 [GO] 2023―Sep―25 42948 COVID-19 and Hospital Acquired Pressure Injuries: A Systematic Review Adrienn N. Bourkas, Michele Zaman, R. Gary Sibbald
6 [GO] 2023―Sep―25 44181 Reactive infectious mucocutaneous eruption secondary to Covid-19 infection Paula Finnegan, Muriel Sadlier
7 [GO] 2023―Sep―25 44451 Cutaneous Reactions of COVID-19 Infection and COVID-19 Vaccines - a Review Amit Singal, Amar D. Desai, Shari R. Lipner
8 [GO] 2023―Sep―25 43672 The Risk of COVID-19 Infection in Psoriasis Patients after Receiving UV-B Phototherapy Sogol Stephanie Javadi, Shahin Shahsavari, Priya Vedula Engel, Jashin J. Wu
9 [GO] 2023―Sep―25 42936 Comparative histopathological features of cutaneous adverse reactions after COVID-19 mRNA- and viral vector-based vaccines Jun Hyuk Cho, Yoon Jae Kim, Sung Jin Park, Dai Hyun Kim, Soo Hong Seo, Hyo Hyun Ahn
10 [GO] 2023―Sep―25 44377 COVID-19 Neurologic and Psychiatric Outcomes on Adults with Psoriasis Rahul Raiker, Haig Pakhchanian, Mairead R. Baker, Min Deng
11 [GO] 2023―Sep―25 42551 Earlier Detection of Invasive Melanoma After the COVID-19 Pandemic Hemali Shah, Rose Parisi, Emily Everdell, Paul Feustel, Lindy Davis
12 [GO] 2023―Sep―25 42407 Teledermatology in Practice: Report of Multi-site Experience During the COVID-19 Pandemic Nessa Aghazadeh Mohandesi, Tudor Puiu, Matthew Hall, Olayemi Sokumbi, Aaron Mangold, Michael Colgan, et al. (+2)
13 [GO] 2023―Sep―25 42406 Gender Representation in Authorship of Academic Dermatology Publications During the COVID-19 Pandemic Mindy Szeto, Melissa Laughter, Mayra Maymone, Payal Patel, Torunn Sivesind, Colby Presley, et al. (+4)
14 [GO] 2023―Sep―25 43455 Dermatology Resident Attitudes towards Virtual Didactics during the COVID-19 Pandemic Marc Schlessel, Frank Wang, Mio Nakamura
15 [GO] 2023―Sep―25 42346 Association of perioral dermatitis and mask usage during the COVID-19 pandemic William J. Nahm, Arielle R. Nagler, Emily C. Milam
16 [GO] 2023―Sep―25 42197 The Impact of the COVID-19 Pandemic on Sun Habits of Patients with Melanoma: A Cross- sectional Study Nicole Trepanowski, Cassandra A. Hathaway, Michael S. Chang, Jennifer L. Hay, Ravi Samatham, Susan M. Swetter, et al. (+4)
17 [GO] 2023―Sep―25 40758 Internet Searches for “Maskne” During the COVID-19 Pandemic: A Call to Action Sarah Shareef, Rafey Rehman, Steven Daveluy, Darius Mehregan
18 [GO] 2023―Sep―25 43129 A series of 69 COVID-related dermatosis with biopsy, immunohistochemistry with antiSpike 3 and in situ hybridization and PCR: a critical reappraisal of COVID-19 skin involvement. Mar Llamas-Velasco, Javier Fraga, Ana Rodríguez-Villa Lario, Alba Catalá, Yosmar Carolina Pérez-González, Beatriz Butrón- Briz, et al. (+5)
19 [GO] 2023―Sep―25 42070 Comparison of COVID-19 Vaccination Rates Among Psoriasis Patients Globally Using the Global Healthcare Study on Psoriasis (GHSP) Edwin Korouri, Hannah Peterson, Fernando Valenzuela, Ricardo Romiti, Johannes Didaskalu, Alexander Egeberg, et al. (+8)
20 [GO] 2023―Sep―25 44156 Vitiligo and Lichen Planus Following COVID-19 Vaccination/Infection: A Possible Type 1 Interferon Response? Maxwell Green, Aileen Feschuk, Nadia Kashetsky, Howard Maibach
21 [GO] 2023―Sep―25 44385 COVID-19’s Neurologic and Psychiatric Effects on Adults with Eczema Haig Pakhchanian, Rahul Raiker, Edward Hochman, Colin Wikholm, Min Deng
22 [GO] 2023―Sep―25 40548 Recurrent Giant Cellulitis-like Sweet Syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine Penelope Hirt, Lily Park, Francisco Kerdel
23 [GO] 2023―Sep―25 42337 Closing Clinical Gaps in Atopic Dermatitis Management Through the Pandemic Era: The Role of Continuing Medical Education Uncovered Pan Chen, Tina Lowes, Anna Bartus, Caitriona Forde
24 [GO] 2023―Sep―25 44321 Impact of the COVID19 pandemic on Non-Melanoma Skin Cancer in Puerto Rico Diana V. Rodriguez-Rivera, Claudia Perez-Draper, Fabiola Pabon- Gonzalez, Idalis Cardona-Ortiz, Sheila Valentin-Nogueras, Luz Figueroa-Guzman
25 [GO] 2023―Sep―05 Onychomycosis not associated with poor COVID-19 clinical outcomes in a retrospective cohort study at an academic institution, NY, NY Kaya L. Curtis, Rhiannon C. Miller, Amar D. Desai, Shari R. Lipner
26 [GO] 2023―Sep―04 Evaluating disruptions in melanoma diagnosis resulting from the COVID-19 pandemic from a community-based perspective Uriel Kim, Richard Hoehn, Gary K. Schwartz, Jennifer Cullen, Jeremy S. Bordeaux, Ankit Mangla, Bryan T. Carroll
27 [GO] 2023―Aug―23 The impact of the COVID-19 pandemic in 2020 on the diagnosis, treatment, and outcomes of invasive cutaneous melanoma: a retrospective national cohort study David D. Xiong, Jeremy Bordeaux
28 [GO] 2023―Aug―09 Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry Eden Lake
29 [GO] 2023―Jun―28 Gaining Perspective on mRNA COVID-19 Vaccination Risk Warren R. Heymann
30 [GO] 2023―May―15 Risk of Autoimmune Skin and Connective Tissue Disorders After mRNA-based COVID-19 Vaccination Hyun Jeong Ju, Ju Yeong Lee, Ju Hee Han, Ji Hae Lee, Jung Min Bae, Solam Lee
31 [GO] 2023―Apr―28 The impact of the American Academy of Dermatology/International League of Dermatological Societies COVID-19 registry during the pandemic: 2500 cases across 72 countries Alexis G. Strahan, Janet E. Lubov, Sonya Prasad, Lindy P. Fox, Devon E. McMahon, Rhea Singh, et al. (+7)
32 [GO] 2023―Apr―23 The impact of the COVID-19 pandemic on new diagnoses of melanoma: a response to additional multi-institution and international reports Adrienne B. Shannon, Giorgos C. Karakousis
33 [GO] 2023―Apr―23 Response to Trepanowski et al.’s “Delays in melanoma presentation during the COVID-19 pandemic: a nationwide multi-institutional cohort study” Claire Drumm, Ciara Griffin, Susan Van Baarsel, Claire Quigley, Stephen Madden, Jarushka Naidoo, Karen Eustace
34 [GO] 2023―Mar―30 Association of Herpes zoster with COVID-19 vaccination: A Systematic Review and Meta-Analysis I-Ling Chen, Hsien-Yi Chiu
35 [GO] 2023―Mar―09 Impact of COVID-19 pandemic on melanoma presentation by facility type and region in the United States Daniel Y. Kim, Sara Behbahani, Rebecca I. Hartman
36 [GO] 2023―Mar―03 Trends in Medicare Part B procedural services performed by dermatology trainees during the Covid-19 pandemic Christian Gronbeck, Donyell Williams, Eric Beltrami, Hao Feng
37 [GO] 2023―Feb―10 Tumor necrosis factor inhibitors and methotrexate are associated with decreased COVID-19-related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate.” Rachel Tallman, Zachary Zinn, Michael S. Kolodney
38 [GO] 2023―Feb―04 Personal Connections and Preference Signaling: A Cross-Sectional Analysis of the Dermatology Residency Match during COVID-19 Yen Luu, Whitney Gao, Joseph Han, Angela Mihalic, Travis Vandergriff
39 [GO] 2022―Nov―26 Comment on "Psoriasis and COVID-19: A bidirectional Mendelian randomization study" Xiaoyu Gu, Xiang Chen, Minxue Shen
40 [GO] 2022―Nov―25 Response to comment on “Psoriasis and COVID-19: A bidirectional Mendelian randomization study” Christos V. Chalitsios, Kostas K. Tsilidis, Ioanna Tzoulaki
41 [GO] 2022―Nov―12 International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) Analysis of CTCL Outcomes During the COVID-19 Pandemic: A Retrospective Cohort Study Larisa J. Geskin, Bradley D. Kwinta, Tiffany J. Garcia-Saleem, Oleg E. Akilov, Paula Enz, Emmanuella Guenova, et al. (+9)
42 [GO] 2022―Oct―14 Psoriasis and COVID-19: A bidirectional Mendelian randomization study Christos V. Chalitsios, Kostas K. Tsilidis, Ioanna Tzoulaki
43 [GO] 2022―Sep―25 Correction to "The association between COVID-19 lockdowns and melanoma diagnosis and thickness: A multicenter retrospective study from Europe"
44 [GO] 2022―Sep―20 The risk of COVID-19 in patients with psoriasis - a retrospective cohort study Jashin J. Wu, Jeffrey Liu, Akshitha Thatiparthi, Amylee Martin, Alexander Egeberg
45 [GO] 2022―Sep―12 35185 Impact of telehealth on duration of tetracycline prescription during COVID-19 Ananya Munjal, Raghav Tripathi, Patrick Kinn, Kelly Percival, Dilek Ince, Jennifer Powers
46 [GO] 2022―Sep―12 33168 Visual vulnerability: Daily burden and psycosocial impact of acne and video calling during COVID-19 Jerry Tan, Anna L. Chien, Krysten Lisella Arekapudi
47 [GO] 2022―Sep―12 34255 Disparity exists between urban versus rural reach of teledermatology following COVID-19 Alison Romisher, Alexa Cohen, Elizabeth Jones
48 [GO] 2022―Sep―12 34926 Dermatology education for medical students in the era of COVID-19 Monika F. Keiser, Quoc-Bao D. Nguyen, Kelly C. Nelson
49 [GO] 2022―Sep―12 32479 Level of evidence of COVID-19 articles in dermatology literature Mehdi Farshchian, Muhammad Osto, Jane M. Grant-Kels
50 [GO] 2022―Sep―12 35393 Changes in the geographic distribution of dermatology matching during the COVID-19 Cycle: A proxy for the value of away rotations Joseph Younis, Bryan T. Carroll
51 [GO] 2022―Sep―12 34296 Introduction of BELCOMID: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases Tom Hillary, An Van Laethem, Francisca Castelijns
52 [GO] 2022―Sep―12 32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study Brian D. Rankin, Jorge-Ryan Georgakopoulos, Muskaan Sachdeva
53 [GO] 2022―Sep―12 34223 Incidence and prognosis of COVID-19 in patients with psoriasis on apremilast: A multicenter retrospective cohort study Yuliya Lytvyn, Jorge R. Georgakopoulos, Asfandyar Mufti
54 [GO] 2022―Sep―12 34346 Pooled safety analysis of respiratory tract infections, including COVID-19, in psoriasis patients treated with secukinumab Hendrik Schulze-Koops, Atul Deodhar, Reinhard E. Voll, Jan Leipe, Andrew Blauvelt, Craig Leonardi, et al. (+5)
55 [GO] 2022―Sep―12 35132 Investigating the progression of melanoma and squamous cell carcinomas before and after the COVID-19 lockdown Laura Russell, Eric Du, Kara Signorelli
56 [GO] 2022―Sep―12 31047 Erythrodermic psoriasis secondary to the COVID-19 Moderna vaccine Gabriela Pabón-Cartagena, Natalia M. Pelet del Toro, Marian Russo
57 [GO] 2022―Sep―12 32433 Effect of COVID-19 on head and neck NMSC at OU Dermatology Justin M. McLawhorn, Lindsey Collins
58 [GO] 2022―Sep―12 33778 The impact and implications of COVID-19 on using scalp cooling therapy for prevention of chemotherapy-induced alopecia Taylor Novice, Madison Novice, Katerina Svigos, Molly Powers, Kristen Lo Sicco
59 [GO] 2022―Sep―12 35309 COVID-19 outcomes among patients with cutaneous T-cell lymphoma: A multicentered analysis Mairead Baker, Haig Pakhchanian, Rahul Raiker, Min Deng
60 [GO] 2022―Sep―12 33642 Personal protective equipment modification by health care workers during the COVID-19 pandemic Nicole Trepanowski, Rachel Meltzer
61 [GO] 2022―Sep―12 32688 Evaluation of demographics for patients on immunomodulatory therapy during the COVID-19 pandemic Ruby S. Gibson, Monica Rosales Santillan, Martina L. Porter
62 [GO] 2022―Sep―12 32689 Comparison of pediatric dermatology diagnoses between virtual and in-person visits during the COVID-19 pandemic Grace Y. Duan, Adena E. Rosenblatt
63 [GO] 2022―Sep―12 32301 A cross sectional study on hand manifestations during COVID-19 pandemic Karthik Sunki
64 [GO] 2022―Sep―12 33892 Telehealth use at a specialty hidradenitis suppurativa clinic during the COVID-19 pandemic Diana S. Kim, Alexa B. Kimball, Martina L. Porter
65 [GO] 2022―Sep―12 34398 Risk factors for the development of acne in health care workers during the COVID-19 pandemic Advika Dani, Amarachi Eseonu, Kristin Bibee
66 [GO] 2022―Sep―12 33340 Patient and provider experience with synchronous teledermatology during the COVID-19 pandemic Saniya Shaikh, Eric Armbrecht, Vruta Kansara
67 [GO] 2022―Sep―12 34543 Isotretinoin counseling amid the COVID-19 pandemic Ayezel Munoz, Renat Ahatov, Emily Williams
68 [GO] 2022―Sep―12 33214 Determining photoprotective effectiveness of face mask during COVID-19 pandemic Sung Jin Park, Jun Hyuk Cho, Min Seok Ham
69 [GO] 2022―Sep―12 33331 Dermatology residency home match incidence during the COVID-19 pandemic Rewan M. Abdelwahab, Luis A. Antezana, Katherine Z. Xie
70 [GO] 2022―Sep―12 34291 Impact of COVID-19 pandemic on dermatology patient pharmacy preferences Ailia Ali, Uros Rakita, Rima Ghamravi
71 [GO] 2022―Sep―12 33027 Telemedicine management of systemic therapy with isotretinoin of patients with moderado-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study Miguel Angel Duarte Ferrera
72 [GO] 2022―Sep―12 34304 Persistence and adherence to ixekizumab treatment in patients with moderate-to-severe psoriasis before and during COVID-19 pandemic: Results from the Canadian Patient Support Program Wayne Gulliver, Melinda Gooderham, Catherine Reed
73 [GO] 2022―Sep―12 33624 Long-term cutaneous manifestations in COVID-19 patients: A systematic review Abhinav Grover, Franchesca Choi, Sheng Pei-Wang
74 [GO] 2022―Sep―12 32731 Alopecia in COVID-19 patients: Systematic review and meta-analysis Betty Nguyen, Antonella Tosti
75 [GO] 2022―Sep―12 35283 Mucocutaneous lichen planus following Moderna COVID-19 vaccination Elnara Muradova, Erica Negrini, Adrienne Berke
76 [GO] 2022―Sep―12 35399 Examining the safety and efficacy of COVID-19 vaccination among atopic dermatitis patients Haig Pakhchanian, Rahul Raiker, Melanie Wolf
77 [GO] 2022―Sep―12 35304 Safety and efficacy of COVID-19 vaccination in psoriasis patients Mairead Baker, Kristen Russomanno, Rahul Raiker
78 [GO] 2022―Sep―12 32390 Duration and recurrence of pityriasis rosea-like reactions following COVID-19 vaccination: A registry based study of 27 cases Devon McMahon, Sonya Prasad, George Hruza
79 [GO] 2022―Sep―12 33925 Global survey shows strong impact of pandemic on skincare routines and skin health Nada Baalbaki
80 [GO] 2022―Sep―12 35158 Adaptations in the PURE registry in response to the COVID 19 pandemic: The impact of well-designed modifications in real-world data collection in a psoriasis registry Charles Lynde, Kim Papp, Jennifer Beecker, Lorne Albrecht, Isabelle Delorme, Ignacio Dei-Cas, et al. (+3)
81 [GO] 2022―Sep―06 The American Academy of Dermatology & International League of Dermatological Societies Monkeypox Registry: Expanding the COVID-19 Registry to Emerging Infections Esther E. Freeman, Cristina Galvan Casas, Sonya Prasad, Claire Fuller, Klint Peebles, Misha Rosenbach, et al. (+12)
82 [GO] 2022―Jul―09 Disease flare in patients with dermatomyositis following COVID-19 vaccination Catherina X. Pan, Nathaniel Goldman, Daniel Y. Kim, Rachael Rowley, Morgan Schaefer, Avery H. LaChance, Vinod E. Nambudiri
83 [GO] 2022―Jul―01 Reply to “Diagnosis of Stress-Associated Dermatological Conditions in New York City Safety Net Hospitals During the Pandemic James T. Pathoulas, Sonia J. Olson, Aneela Idnani, Ronda S. Farah, Maria K. Hordinsky, Alik Widge
84 [GO] 2022―Jun―30 Diagnosis of Stress-Associated Dermatological Conditions in New York City Safety Net Hospitals During the Pandemic Kristy R. Tefft, Sarah Balboul, Bijan Safai, Abigail Cline, Shoshana Marmon
85 [GO] 2022―Jun―25 COVID-19 Booster Exemption for Severe Dyshidrotic Eczema Kathryn Bentivegna, Marti J. Rothe, Jane M. Grant Kels
86 [GO] 2022―Jun―20 Delays in melanoma presentation during the COVID-19 pandemic: a nationwide multi-institutional cohort study Nicole Trepanowski, Michael S. Chang, Guohai Zhou, Maham Ahmad, Elizabeth G. Berry, Katherine Bui, et al. (+30)
87 [GO] 2022―Jun―19 This Month in JAAD International: August 2022: Cutaneous reactions to COVID-19 mRNA booster dose vaccination Jonathan Kantor
88 [GO] 2022―May―17 THE ASSOCIATION BETWEEN LOCKDOWNS DURING THE COVID-19 PANDEMIC AND MELANOMA DIAGNOSIS: A MULTICENTER RETROSPECTIVE STUDY FROM EUROPE C. Scharf, G. Brancaccio, A. Di Stefani, M.C. Fargnoli, H. Kittler, A. Kyrgidis, et al. (+9)
89 [GO] 2022―May―16 Prevalence of SARS-CoV-2 Infection in Asymptomatic Pre-operative Patients Scheduled for Dermatologic Surgery: A Single Center, Retrospective Chart Review Selcen S. Yuksel, Alvin W. Li, Simon S. Yoo
90 [GO] 2022―May―13 Pemphigus Vulgaris after COVID-19 Infection and Vaccination Henry Zou, Steven Daveluy
91 [GO] 2022―May―13 “Comparison of Patient Demographics at a Free Clinic Prior-to versus During the COVID-19 Pandemic Paige Hoyer, Jenna Reisler, Sruti Rachapudi, Lindy Ross
92 [GO] 2022―May―13 Proposing a Standardized Assessment of COVID-19 Vaccine Cutaneous Reactions Rhea Singh, Rowanne Ali, Sonya Prasad, Steven T. Chen, Kimberly Blumenthal, Esther E. Freeman
93 [GO] 2022―May―10 Tofacitinib Therapy for Alopecia Areata is not Associated with Adverse Events during COVID-19 Infection Soundos Youssef, Jonathan Lavian, Eunice Y. Lee, Weijia Fan, Lindsey A. Bordone
94 [GO] 2022―May―10 A Retrospective Analysis of the Impact of the COVID-19 Pandemic on Staging at Presentation of Patients with Invasive Melanoma Saba S. Shaikh, Xi Yang, Dylan D. Fortman, Hong Wang, Diwakar Davar, Jason J. Luke, et al. (+3)
95 [GO] 2022―Apr―28 An Analysis of Internal and Regional Dermatology Matches During the Second Year of the COVID-19 Pandemic: a Cross Sectional Study Travis S. Dowdle, Michael P. Ryan, Michelle B. Tarbox, Richard F. Wagner
96 [GO] 2022―Mar―30 COVID-19 vaccination in IMID patients receiving rituximab: a personalized regimen should be formulated Qian Yang, Qi Jiang, Man Man Niu, Guo Zhen Fan, Peng Hu
97 [GO] 2022―Mar―29 Reply to: COVID-19 vaccination in IMID patients receiving rituximab: a personalized regimen should be formulated Vartan Pahalyants, William S. Murphy, Nikolai Klebanov, Chen Lu, Nicholas Theodosakis, R. Monina Klevens, et al. (+4)
98 [GO] 2022―Mar―09 Factors Influencing Willingness to Pay and Show Images with Teledermatology during the COVID-19 pandemic Choi CE. Ellie, Heng Li Wei, Tan YL. Sean, Phan HC. Phillip, Nisha Suyien Chandran
99 [GO] 2022―Mar―08 Telemedicine Management of Systemic Therapy with Isotretinoin of Patients with Moderate-to-Severe Acne During the COVID-19 Pandemic. a Longitudinal Prospective Feasibility Study D. Moreno-Ramírez, M.A. Duarte-Ferreras, T. Ojeda-Vila, I. García-Morales, M.D. Conejo-Mir, A. Fernández-Orland, et al. (+7)
100 [GO] 2022―Feb―25 Predictors of COVID-19 Disease Severity Augment the Braden Scale in the Prediction of Pressure Ulcer Development among COVID-19-Positive Intensive Care Unit Patients: A Case-Control Study Brett D. McLarney, Claire L. Le Guen, Simo Huang, Frederick Ramsey, Rohit Soans, Sylvia Hsu
101 [GO] 2022―Feb―04 Association of psoriasis with risk of COVID-19: A two-sample Mendelian randomization study Xiaoyu Gu, Xiang Chen, Minxue Shen
102 [GO] 2022―Jan―29 Psoriatic lesional expression of SARS-CoV-2 receptor ACE2 is reduced by blockade of IL-17 signaling but not by other biologic treatments Ge Peng, Ko Okumura, Hideoki Ogawa, Shigaku Ikeda, François Niyonsaba
103 [GO] 2022―Jan―25 An Analysis of Public Sunscreen Distribution in the United States During the COVID-19 Pandemic Mindy D. Szeto, Ryan E. Kokoska, Jalal Maghfour, Chandler W. Rundle, Colby L. Presley, Taylor Harp, et al. (+4)
104 [GO] 2022―Jan―10 The effect of biologic therapy for immune-mediated inflammatory diseases on clinical outcomes of COVID-19 in the Greater Houston Area: a retrospective chart review Kevin P. Lee, Misha V. Koshelev, Omar Pacha
105 [GO] 2021―Dec―23 This Month in JAAD Case Reports: March 2022 RIME secondary to SARS-CoV-2 Brett Sloan
106 [GO] 2021―Dec―18 Asymmetric patterns of patient access to in-person and teledermatologic healthcare during the COVID-19 pandemic Chirag Vasavda, Olive Tang, Shawn G. Kwatra, Byron K. Ho, Anna L. Grossberg
107 [GO] 2021―Dec―17 Maintaining patient involvement in dermatology education during the COVID-19 pandemic: Challenges and solutions Connie R. Shi, Lori R. Newman, Bina Kassamali, Susan Burgin
108 [GO] 2021―Dec―16 Cross-sectional Study of Dermatology Residency Home Match Incidence During the COVID-19 Pandemic Rewan Abdelwahab, Luis A. Antezana, Katherine Z. Xie, Muhab Abdelwahab, Megha Tollefson
109 [GO] 2021―Dec―11 Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium Carlos Gustavo Wambier, Antonella Tosti
110 [GO] 2021―Dec―11 Early onset effluvium secondary to COVID-19: A clinical and histological characterization Anna Carolina Miola, Lívia Caramaschi Florêncio, Maria Estela Bellini Ribeiro, Giovana Piteri Alcântara, Paulo Müller Ramos, Hélio Amante Miot
111 [GO] 2021―Dec―06 This Month in JAAD International: March 2022: Photography, skin cancer, and the limits of teledermatology in the COVID-19 pandemic Jonathan Kantor
112 [GO] 2021―Dec―04 Impact of COVID-19 Delays on Skin Cancer Worry and Mohs Surgery for Keratinocytic Carcinoma Emily Stamell Ruiz, Inge J. Veldhuizen, Aleisa Abdullah, Anthony Rossi, Kishwer S. Nehal, Chrysalyne Schmults, et al. (+2)
113 [GO] 2021―Nov―25 Pediatric Teledermatology: A retrospective review of 1199 encounters during the COVID-19 pandemic Sonia A. Havele, Ramie Fathy, Patrick McMahon, Aditi S. Murthy
114 [GO] 2021―Nov―23 Risk of Herpes Zoster Reactivation After mRNA COVID-19 Vaccination: A Cohort Study Morgan Birabaharan, David C. Kaelber, Maile Y. Karris
115 [GO] 2021―Nov―18 Response to McMahon et al.’s “Cutaneous reactions reported after Modrna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases” Konstantinos Poulas, Konstantinos Farsalinos
116 [GO] 2021―Nov―17 Skin Reactions to COVID-19 Vaccines: an AAD/ILDS Registry Update on reaction location and COVID vaccine type Esther E. Freeman, Qisi Sun, Devon E. McMahon, Rhea Singh, Ramie Fathy, Anisha Tyagi, et al. (+4)
117 [GO] 2021―Oct―29 Incidence and Severity of COVID-19 in patients with autoimmune blistering skin diseases: a nation-wide study Pascal Joly, André Gillibert, Gérôme Bohelay, Karen Aouar, Saskia Ingen-Housz-Oro, Christophe Bedane, et al. (+21)
118 [GO] 2021―Oct―07 The risk of COVID-19 infection in patients with atopic dermatitis - a retrospective cohort study Jashin J. Wu, Amylee Martin, Jeffrey Liu, Akshitha Thatiparthi, Shaokui Ge, Alexander Egeberg, Jacob P. Thyssen
119 [GO] 2021―Sep―28 Comparison of constitutional and dermatologic side effects between COVID-19 and non-COVID-19 vaccines: review of a publicly available database of vaccine side effects Stephanie R. Cohen, David X. Gao, Jared S. Kahn, David Rosmarin
120 [GO] 2021―Sep―22 Impact of the COVID-19 pandemic on hospitalizations of patients with moderate to severe skin diseases: A retrospective cohort analysis from a Central European Center Franziska Schauer, Max Behrens, Sabine Müller, Frank Meiss, Dimitra Kiritsi
121 [GO] 2021―Sep―16 Biologic therapy is not associated with increased COVID-19 severity in Hidradenitis Suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry H.B. Naik, R. Alhusayen, J. Frew, S. Guilbault, N.K. Hills, J.R. Ingram, et al. (+6)
122 [GO] 2021―Sep―10 This Month in JAAD International: November 2021: COVID-19 and hair loss Jonathan Kantor
123 [GO] 2021―Sep―10 Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: a retrospective matched cohort study from Massachusetts Vartan Pahalyants, William S. Murphy, Nikolai Klebanov, Chenyue Lu, Nicholas Theodosakis, R. Monina Klevens, et al. (+4)
124 [GO] 2021―Sep―10 Utilizing Simulation Modeling to Minimize Patient-to-Patient Contact Time While Optimizing Clinical Operations During a Pandemic Shilpa Ghatnekar, Nurul M. Suhaimi, Jacqueline Griffin, David Rosmarin, Rebecca Yanovsky, Priyank Sharma, F. Clarissa Yang
125 [GO] 2021―Sep―10 Clinical and Pathologic Correlation of Cutaneous COVID-19 Vaccine Reactions including V-REPP: A Registry Based Study Devon E. McMahon, Carrie L. Kovarik, William Damsky, Misha Rosenbach, Jules B. Lipoff, Anisha Tyagi, et al. (+11)
126 [GO] 2021―Aug―28 Comment on “The Impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: a single institution experience” O. McFeely, A. Hollywood, M. Stanciu, M. O’Connell, L. Paul
127 [GO] 2021―Aug―23 Dermatology Patients on Biologics and Certain Other Systemic Therapies Should Receive a ‘Booster’ mRNA COVID-19 Vaccine Dose: A Critical Appraisal of Recent FDA and ACIP Recommendations Reid A. Waldman, Jane M. Grant-Kels
128 [GO] 2021―Aug―18 Instagram Usage and Engagement by Dermatology Residency Programs during the COVID-19 Pandemic compared with Twitter and Facebook Taylor Harp, Mindy D. Szeto, Colby L. Presley, Abigail L. Meckley, Ryan Geist, Jaclyn Anderson, et al. (+4)
129 [GO] 2021―Aug―14 Successful Implementation of Phototherapy Guidelines during the COVID-19 Pandemic Emma Dragan, Ariel Sher, Peter Xiong, Abigail Cline, Janet Moy
130 [GO] 2021―Aug―14 Response to a letter to the editor regarding “Utilization of Instagram by Dermatology Residency Programs in the era of COVID-19 Gabrielle Schwartzman, Azam Qureshi, Adam J. Friedman
131 [GO] 2021―Aug―14 Response to Implementation of Phototherapy Guidelines during Pandemic Henry W. Lim, Steve R. Feldman, Abby S. Van Voorhees, Joel M. Gelfand
132 [GO] 2021―Aug―08 Internal and Geographic Dermatology Match Trends in the Age of COVID-19 Travis S. Dowdle, Michael P. Ryan, Richard F. Wagner
133 [GO] 2021―Aug―07 28665 Cutaneous T-cell lymphoma (CTCL) outcomes during COVID-19 Tiffany J. Garcia-Saleem, Connor J. Stonesifer, Larisa J. Geskin
134 [GO] 2021―Aug―07 25587 The experience of COVID-19 and its impact on management of hidradenitis suppurativa Gabrielle Benesh, Tyler M. Andriano, Kayla M. Babbush, Steven R. Cohen
135 [GO] 2021―Aug―07 28552 Risk of COVID-19 and subsequent mortality among patients receiving immunosuppressive biologic therapy: A retrospective matched cohort study Vartan Pahalyants, William S. Murphy, Nikolai Klebanov, Nicholas Theodosakis, R. Monina Klevens, Evelyn Lilly, et al. (+2)
136 [GO] 2021―Aug―07 27804 A cross-sectional study on the association between COVID-19 infection and hospitalization in patients with alopecia areata Niki Nourmohammadi, Fiore Casale, Katerina Yale, Alessandro Ghigi, Kai Zheng, Natasha Mesinkovska
137 [GO] 2021―Aug―07 26452 Impact of COVID-19 on patient willingness to seek in-person dermatologic care Rima I. Ghamrawi, Esther A. Balogh, Matthew L. Hrin, Quan Pham, Jacob J. Subash, William W. Huang, Steven R. Feldman
138 [GO] 2021―Aug―07 28561 The impact of telemedicine on the delivery of dermatologic care during the COVID-19 pandemic Vartan Pahalyants, William Murphy, Nicole Gunasekera, Daniela Kroshinsky
139 [GO] 2021―Aug―07 26726 A case of transient reactive papulotranslucent acrokeratoderma: Exploring the role of epidermal barrier dysfunction during the COVID-19 pandemic Victoria McCarver, Risa Ross, Richard Miller
140 [GO] 2021―Aug―07 26189 Patient Satisfaction with Teledermatology during the Covid-19 Pandemic Judy Hamad, Amy W. Fox, Maria S. Kammire, Alison N. Hollis, Saif Khairat
141 [GO] 2021―Aug―07 25777 Trends in telemedicine utilization and access for dermatologic concerns during the COVID-19 pandemic Michelle S. Lee, Lisa N. Guo, Vinod E. Nambudiri
142 [GO] 2021―Aug―07 28181 A retrospective review of continuation and discontinuation rates of biologic therapy during the COVID-19 pandemic in a single academic center dermatology practice Stephanie R. Cohen, David X. Gao, Jared S. Kahn, Anh H. Lam, Kristin Fiumara, David Rosmarin
143 [GO] 2021―Aug―07 27313 The effect of the COVID-19 pandemic on patients’ perceptions of teledermatology Sophia Ly, Caroline Porter, Steven R. Feldman
144 [GO] 2021―Aug―07 28620 The impact of the COVID-19 pandemic on perceived hair loss and stress in a cohort of alopecia areata patients: A cross-sectional study Chloe J. Walker, Kelly E. Flanagan, James T. Pathoulas, Isabel Pupo Wiss, Abby Ellison, Natasha Mesinkovska, Maryanne M. Senna
145 [GO] 2021―Aug―07 26780 Patient experiences with teledermatology during the COVID-19 pandemic: A survey Samuel Yeroushalmi, Sarah Hannah Millan, Kamaria Nelson, Andrew Sparks, Adam Friedman
146 [GO] 2021―Aug―07 28630 Use of systemic immunosuppressive treatment is not related to COVID-19 positivity in a retrospective review of patients in Massachusetts William Murphy, Nikolai Klebanov, Vartan Pahalyants, Nicholas Theodosakis, Kevin Patel, R. Monina Klevens, et al. (+2)
147 [GO] 2021―Aug―07 26033 Exacerbation and appearance of dermatosis during COVID-19 quarantine period in Bogotá, Colombia: A descriptive study of the psychological impairments David A. Castillo Molina, Jesus D. Fierro Lozada, Luisa F. Camacho-Lazaro, Mariana Reyes Rey, Daniela M. Molina Dorado, Maria Daniela Polania Tovar, et al. (+4)
148 [GO] 2021―Aug―07 26021 Delivering care for the underserved during COVID-19 through real-time teledermatology, a cross-sectional review of patients at a student-run free clinic in Dallas Ramiro Rodriguez, Orlando Martinez-Luna, Rebecca Vasquez
149 [GO] 2021―Aug―07 26945 Purpuric pressure ulcers in hospitalized patients with COVID-19: A case series Sidharth Chand, Renajd Rrapi, Jennifer Lo, Sarah Song, Colleen Gabel, Niyati Desai, et al. (+2)
150 [GO] 2021―Aug―07 27147 Antimalarials as pre-exposure prophylaxis for COVID-19: A retrospective matched cohort study Nikolai Klebanov, Vartan Pahalyants, William S. Murphy, Jordan T. Said, Nicholas Theodosakis, Stacey Duey, et al. (+4)
151 [GO] 2021―Aug―07 28522 The impact of the SARS-CoV-2 pandemic on phototherapy utilization Aunna Pourang, Hailey Olds, Nneamaka Ezekwe, Henry W. Lim, Iltefat Hamzavi
152 [GO] 2021―Aug―07 26433 Interventions for skin wellbeing clinics in for health care staff during the SARS-CoV2 outbreak: A perspective from London (UK) Nav Paul, Monika Saha, Marie-Louise Daly, Luigi Citarella, Antonia D’Cruz, Athina Fonia, et al. (+4)
153 [GO] 2021―Aug―07 28575 Caring for skin during a pandemic: Acute facial skin changes following mask-wearing Rachel Elsanadi, Fiore Casale, Niki Nourmohammadi, Katerina Yale, Cristina Nguyen, Vardit Eckhouse, et al. (+2)
154 [GO] 2021―Aug―04 COVID-19 vaccine safety and efficacy in patients with Immune-Mediated Inflammatory Disease: Review of available evidence Sarah Wack, Timothy Patton, Laura K. Ferris
155 [GO] 2021―Jul―24 Expanding Teledermatology Educational Opportunities after COVID-19 Shahzeb Hassan, Mohannad G. Safadi, Taha O. Mohammed, Jules B. Lipoff
156 [GO] 2021―Jul―21 Flipped classroom curriculum for dermatologic surgery during COVID-19: A prospective cohort study Michael Tassavor, Aatman Shah, Peter Hashim, Richard Torbeck
157 [GO] 2021―Jul―16 An Increase in Respiratory Protection Device Injuries Associated with the COVID-19 Pandemic Gerald McGwin, Madeleine McGwin, Russell L. Griffin
158 [GO] 2021―Jun―14 Clinical Manifestations and Patch test Results for Facial Dermatitis Associated with use of Disposable Face Masks during the COVID-19 Outbreak : A case-control study Seok Young Kang, Bo Young Chung, Jin Cheol Kim, Chun Wook Park, Hye One Kim
159 [GO] 2021―Jun―08 July 2021: Lisinopril for delayed inflammatory responses to hyaluronic acid fillers after COVID-19 vaccinations Brett Sloan
160 [GO] 2021―Jun―05 Importance of nose wires in face masks in reply to: “Diagnostic and management considerations for “maskne” in the era of COVID-19 Bina Kassamali, Kylee JB. Kus, Michelle S. Min, Gabriela A. Cobos, Avery H. LaChance, Daniel R. Mazori
161 [GO] 2021―May―27 Delayed skin cancer diagnosis in 2020 due to the COVID-19-related restrictions: data from an institutional registry Aimilios Lallas, Athanassios Kyrgidis, Sofia-Magdalini Manoli, Chryssoula Papageorgiou, Konstantinos Lallas, Elena Sotiriou, et al. (+4)
162 [GO] 2021―May―26 Mild to moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients. Lidia Rudnicka, Adriana Rakowska, Anna Waskiel-Burnat, Marta Kurzeja, Malgorzata Olszewska
163 [GO] 2021―May―12 Genetic correlation analysis does not associate male pattern baldness with COVID-19 Hamzeh M. Tanha, Sarah Medland, Nicholas G. Martin, Dale R. Nyholt
164 [GO] 2021―May―12 Differences in Virtual Care Utilization for Acne for Vulnerable Populations during the COVID-19 Pandemic: A Retrospective Review Michelle S. Lee, Bina Kassamali, Nidhi Shah, Avery LaChance, Vinod E. Nambudiri
165 [GO] 2021―Apr―17 Response to Comment on “An Evidence-Based Guide to SARS-Cov-1 2 Vaccination of Patients on Immunotherapies in Dermatology.” Louise M. Gresham, Barbara Marzario, Jan Dutz, Mark G. Kirchhof
166 [GO] 2021―Apr―08 Race, Ethnicity and Comorbidities are Critical Factors in the Diagnosis of Telogen Effluvium During the COVID- 19 Pandemic Abigail Cline, Ashley Keyes Jacobs, Maira Fonseca, Julia Wu, Falguni Asrani, Bijan Safai, et al. (+4)
167 [GO] 2021―Apr―07 Cutaneous Reactions Reported after Moderna and Pfizer COVID-19 Vaccination: A Registry-Based Study of 414 Cases Devon E. McMahon, Erin Amerson, Misha Rosenbach, Jules B. Lipoff, Danna Moustafa, Anisha Tyagi, et al. (+8)
168 [GO] 2021―Apr―03 #DermTwitter and digital mentorship in the COVID-19 era David X. Zheng, Kathleen M. Mulligan, Jeffrey F. Scott
169 [GO] 2021―Apr―02 Mucocutaneous Manifestations in Hospitalized Children with COVID-19 David Andina-Martinez, Montserrat Nieto-Moro, Jose Antonio Alonso-Cadenas, Juan Añon-Hidalgo, Angela Hernandez-Martin, Esther Perez-Suarez, et al. (+5)
170 [GO] 2021―Apr―01 Utilization of Instagram by Dermatology Residency Programs in the era of COVID-19 Gabrielle Schwartzman, Azam Qureshi, Adam J. Friedman
171 [GO] 2021―Mar―27 May 2021: Heterogeneity in reported skin manifestations of COVID-19 and vaccines Jonathan Kantor
172 [GO] 2021―Mar―23 Cutaneous manifestations of SARS-CoV-2 - a two-center, prospective, case-controlled study L. Unterluggauer, I. Pospischil, C. Krall, S. Saluzzo, S. Kimeswenger, M. Karolyi, et al. (+9)
173 [GO] 2021―Mar―20 The Significance of Pressure Injuries and Purpura in COVID-19 Patients Hospitalized at a Large Urban Academic Medical Center: A Retrospective Cohort Study Renajd Rrapi, Sidharth Chand, Jennifer A. Lo, Colleen K. Gabel, Sarah Song, Zachary Holcomb, et al. (+9)
174 [GO] 2021―Mar―18 Preliminary Outcomes of 2020-2021 Dermatology Residency Application Cycle and Adverse Effects of COVID-19 Akshitha Thatiparthi, Amylee Martin, Jeffrey Liu, Jashin J. Wu
175 [GO] 2021―Mar―18 The risk of Coronavirus disease 2019 (COVID-19) in patients with bullous pemphigoid and pemphigus: A population-based cohort study Khalaf Kridin, Yochai Schonmann, Orly Weinstein, Enno Schmidt, Ralf J. Ludwig, Arnon D. Cohen
176 [GO] 2021―Mar―18 Comment on “An Evidence-Based Guide to SARS-Cov-2 Vaccination of Patients on Immunotherapies in Dermatology.” Reinhart Speeckaert, Jo Lambert, Luis Puig, Marijn Speeckaert, Hilde Lapeere, Sofie De Schepper, Nanja van Geel
177 [GO] 2021―Mar―13 Dermatology applicant perspectives of a virtual visiting rotation in the era of COVID-19 Nagasai C. Adusumilli, Jessica Kalen, Kayleigh Hausmann, Adam J. Friedman
178 [GO] 2021―Mar―05 A response to ‘’Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children’’ Ahmet Sert
179 [GO] 2021―Feb―26 COVID-19 impacts on dermatologic surgery patients: a single institution experience Melissa J. Danesh, Martina Porter, Katherine Brag, Prerna Salian, Suzanne Olbricht
180 [GO] 2021―Feb―25 Comment on “The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries” Kelsey Baab, Cory Dunnick, Robert P. Dellavalle
181 [GO] 2021―Feb―25 Reply To “Comment on ‘The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries’” Esther E. Freeman, Devon E. McMahon, Seemal R. Desai, Lindy P. Fox
182 [GO] 2021―Feb―11 COVID-19 in Melanoma Patients: Results of the Spanish Melanoma Group Registry, GRAVID study Maria Gonzalez-Cao, Cristina Carrera, Juan Francisco Rodriguez Moreno, Pedro Rodríguez-Jiménez, Mónica Antoñanzas Basa, Rosa Feltes Ochoa, et al. (+26)
183 [GO] 2021―Feb―05 Seroconversion of SARS-CoV-2 infected patients on immunosuppression: a retrospective analysis Jeffrey S. Smith, Jordan T. Said, Scott A. Elman, Claire E.P. Smith, Joseph F. Merola
184 [GO] 2021―Jan―19 The clinical spectrum of COVID-19-associated cutaneous manifestations: an Italian multicentre study of 200 adult patients Angelo Valerio Marzano, Giovanni Genovese, Chiara Moltrasio, Valeria Gaspari, Pamela Vezzoli, Vincenzo Maione, et al. (+22)
185 [GO] 2021―Jan―19 The Magnitude of COVID-19’s Effect on the Timely Management of Melanoma and Non-Melanoma Skin Cancers Justin W. Marson, Brittany S. Maner, Tanner P. Harding, John Meisenheimer, James A. Solomon, Matt Leavitt, et al. (+4)
186 [GO] 2021―Jan―19 An Evidence-Based Guide to SARS-CoV-2 Vaccination of Patients on Immunotherapies in Dermatology Louise M. Gresham, Barbara Marzario, Jan Dutz, Mark G. Kirchhof
187 [GO] 2021―Jan―11 Chronic Hydroxychloroquine Therapy and COVID-19 Outcomes: A Retrospective Case-Control Analysis Lauren K. Rangel, Payal Shah, Kristen Lo Sicco, Avrom S. Caplan, Alisa Femia
188 [GO] 2021―Jan―08 National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 2 - Advances in Psoriatic Disease Management, COVID-19 Vaccines, and COVID-19 Treatments J.M. Gelfand, A.W. Armstrong, S. Bell, G.L. Anesi, A. Blauvelt, C. Calabrese, et al. (+21)
189 [GO] 2020―Dec―25 Eruptions and Related Clinical Course Among 296 Hospitalized Adults with Confirmed COVID-19 Sergey Rekhtman, Rachel Tannenbaum, Andrew Strunk, Morgan Birabaharan, Shari Wright, Nicole Grbic, et al. (+8)
190 [GO] 2020―Dec―25 Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: a retrospective cohort study Hamidreza Mahmoudi, Ali Salehi Farid, Ali Nili, Dorsa Dayani, Soheil Tavakolpour, Tahereh Soori, et al. (+5)
191 [GO] 2020―Dec―25 The Impact of the COVID-19 Pandemic on the Presentation Status of Newly Diagnosed Melanoma: A Single Institution Experience Adrienne B. Shannon, Cimarron E. Sharon, Richard J. Straker, John T. Miura, Michael E. Ming, Emily Y. Chu, Giorgos C. Karakousis
192 [GO] 2020―Dec―11 Trends in teledermatology utilization during clinic reopening following COVID-19 closures Mack Y. Su, Gideon P. Smith, Shinjita Das
193 [GO] 2020―Dec―10 A Surge in the Incidence of Telogen Effluvium in Minority Predominant Communities Heavily Impacted by COVID-19 Abigail Cline, Abrahem Kazemi, Janet Moy, Bijan Safai, Shoshana Marmon
194 [GO] 2020―Dec―10 Impact of Paycheck Protection Program on dermatology practices during the COVID-19 pandemic. Imene Ben lagha, Bichchau Michelle Nguyen
195 [GO] 2020―Dec―05 Dermatological surgery during the COVID-19 pandemic: experience of a large academic center Michael W. Tee, Claire Stewart, Saud Aliessa, Max Polansky, Kalee Shah, Tatyana Petukhova, et al. (+3)
196 [GO] 2020―Dec―03 Cross-sectional Survey Examining Skin Picking and Hair Pulling Disorders During The COVID-19 Pandemic James T. Pathoulas, Sonia J. Olson, Aneela Idnani, Ronda S. Farah, Maria K. Hordinsky, Alik Widge
197 [GO] 2020―Nov―27 The oral cavity cannot be forgotten in the COVID-19 era: is there a connection between dermatological and oral manifestations? Larissa Marques Bemquerer, José Alcides Almeida de Arruda, Marina Pereira Dias Soares, Ricardo Alves Mesquita, Tarcília Aparecida Silva
198 [GO] 2020―Nov―19 Retrospective Study of Trends in Dermatology Telemedicine and In-Person Visits at an Academic Center During COVID-19 Rhiannon C. Miller, Claire R. Stewart, Shari R. Lipner
199 [GO] 2020―Nov―19 A glossary of pandemic-related terms Benjamin B. Norton, David M. Morens, Scott A. Norton
200 [GO] 2020―Nov―12 Impact of the COVID-19 pandemic on inpatient dermatology consult patterns at a tertiary care hospital: A retrospective cohort study Meredith C. Rogers, Matthew M. Wallace, Lee Wheless, Anna K. Dewan
201 [GO] 2020―Nov―05 If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19 Qiannan Xu, Lihong Chen, Xia Li, Jie Zheng
202 [GO] 2020―Oct―30 Evidence Following Guidelines: Another COVID-19 Paradox Warren R. Heymann
203 [GO] 2020―Oct―30 Letter in Reply: Toward a COVID-19 Vaccine Strategy for Pemphigus Patients on Rituximab Reid A. Waldman, Marina Creed, Kelley Sharp, Jonas Adalsteinnson, Jaime Imitola, Timothy Durso, Jun Lu
204 [GO] 2020―Oct―28 Analysis of Availability of Online Dermatology Appointments During COVID-19 Lilly Gu, Laura Xiang, Shari Lipner
205 [GO] 2020―Oct―26 Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: a Biobadaderm cohort analysis O. Baniandrés-Rodríguez, J. Vilar-Alejo, R. Rivera, J.M. Carrascosa, E. Daudén, E. Herrera-Acosta, et al. (+19)
206 [GO] 2020―Oct―24 Mucocutaneous Disease and Related Clinical Characteristics in Hospitalized Children and Adolescents with COVID-19 and MIS-C Sergey Rekhtman, Rachel Tannenbaum, Andrew Strunk, Morgan Birabaharan, Shari Wright, Amit Garg
207 [GO] 2020―Oct―24 Letter to the Editor: A response to ‘Male Balding is a Major Risk Factor for Severe COVID-19 Akshitha Thatiparthi, Jeffrey Liu, Amylee Martin, Jashin J. Wu
208 [GO] 2020―Oct―24 Reply to letter to the editor: “A response to ‘Male Balding is a Major Risk Factor for Severe COVID-19’” Ahmed Yousaf, Michael Kolodney
209 [GO] 2020―Oct―23 COVID-19 and healthcare disparities: Innovative ways to meet the dermatologic needs of patients experiencing homelessness Samantha M. Guhan, Neera R. Nathan, Haya Raef, Margaret Cavanaugh-Hussey, Jennifer K. Tan
210 [GO] 2020―Oct―16 Hydroxychloroquine prescribing habits and impact by the COVID-19 pandemic Drew Kuraitis, Andrea Murina
211 [GO] 2020―Oct―14 Cutaneous findings in hospitalized and critically-ill patients with COVID-19: A case series of 15 patients Mark A. Strom, Megan H. Trager, Dmitriy Timerman, Alexandra J. Coromilas, Katy Burris, Donald V. Belsito, et al. (+22)
212 [GO] 2020―Oct―04 CHILBLAIN-LIKE LESIONS AND COVID-19 INFECTION: A PROSPECTIVE OBSERVATIONAL STUDY AT SPAIN´S GROUND ZERO M. Feito-Rodríguez, A. Mayor-Ibarguren, Cámara Hijón, D. Montero-Vega, G. Servera-Negre, E. Ruiz-Bravo, et al. (+13)
213 [GO] 2020―Oct―01 Diagnostic and Management Considerations for ‘Maskne’ in the Era of COVID-19 Wan-Lin Teo
214 [GO] 2020―Oct―01 COVID-19 Compels Closer Scrutiny of Disparities in Dermatology Laurie A. Temiz, Lynn McKinley-Grant, Donald A. Glass, Valerie M. Harvey
215 [GO] 2020―Oct―01 Comment on “Cling film for mobile phones to prevent cross-infection during the COVID-19 pandemic Andac Salman, Elif Cömert-Özer, Kübra Esen-Salman
216 [GO] 2020―Sep―30 The Continuing Impact of COVID-19 on Dermatology Practice: Office Workflow, Economics and Future Implications Graham H. Litchman, Justin W. Marson, Darrell S. Rigel
217 [GO] 2020―Sep―30 Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: A multicenter study on 10 patients Vincenzo Piccolo, Andrea Bassi, Giuseppe Argenziano, Carlo Mazzatenta, Alba Guglielmo, Annalisa Patrizi, Iria Neri
218 [GO] 2020―Sep―30 Response to: “Applying to dermatology residency during the COVID-19 pandemic Erisa Alia, Lauren Skudalski, Jun Lu
219 [GO] 2020―Sep―30 Reply to Letter to the Editor Regarding: “Applying to dermatology residency during the COVID-19 pandemic Donovan G. Kearns, Shelley Uppal, Vipawee S. Chat, Jashin J. Wu
220 [GO] 2020―Sep―17 A national webinar for dermatology applicants during the COVID-19 pandemic Caitlin M. Brumfiel, Itisha S. Jefferson, Albert G. Wu, Jennifer L. Strunck, Surya Veerabagu, Krysta Lin, et al. (+2)
221 [GO] 2020―Sep―17 Occupational Dermatoses Among Frontline Healthcare Workers During the COVID-19 Pandemic: A Cross-Sectional Survey Nicole Trepanowski, Allison R. Larson, Rachel Evers-Meltzer
222 [GO] 2020―Sep―15 Patient and Physician Perspectives on Teledermatology at an Academic Dermatology Department amid the COVID-19 Pandemic Emmanuella Ngozi Asabor, Christopher G. Bunick, Jeffrey M. Cohen, Sara H. Perkins
223 [GO] 2020―Sep―15 Absence of specific cutaneous manifestations of SARS-Cov-2 in a reference center in Brazil Joao Avancini, Denise Miyamoto, Marcelo Arnone, Tatiana Villas-Boas Gabbi, Paula Silva Ferreira, Cyro Festa Neta, Jose Antonio Sanches
224 [GO] 2020―Sep―11 Clinical Outcomes of CoVid-19 in Patients Taking Tumor Necrosis Factor Inhibitors and/or Methotrexate: A Multi-Center Research Network Study Ahmed Yousaf, Swapna Gayam, Steve Feldman, Zachary Zinn, Michael Kolodney
225 [GO] 2020―Sep―11 Male balding as a major risk factor for severe COVID-19: a possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals Carlos Gustavo Wambier, John McCoy, Andy Goren
226 [GO] 2020―Sep―10 Timing of PCR and Antibody Testing in Patients with COVID-19 associated dermatologic manifestations Esther E. Freeman, Devon E. McMahon, George J. Hruza, Jules B. Lipoff, Lars E. French, Lindy P. Fox, Marlys S. Fassett
227 [GO] 2020―Sep―04 Reply to “Treatment considerations for patients with pemphigus during the COVID-19 pandemic Brittney Schultz, David R. Pearson, Matthew Mansh
228 [GO] 2020―Sep―04 Authors’ Reply to the comment ‘Treatment considerations for patients with pemphigus during the COVID-19 pandemic Hadir Shakshouk, Maryam Daneshpazhooh, Dedee F. Murrell, Julia S. Lehman
229 [GO] 2020―Sep―04 National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1 J.M. Gelfand, A.W. Armstrong, S. Bell, G.L. Anesi, A. Blauvelt, C. Calabrese, et al. (+22)
230 [GO] 2020―Aug―26 Effect of anti-tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in psoriasis patients - A meta-estimate of pivotal phase 3 trials relevant to decision-making during the COVID-19 pandemic Maha N. Syed, Mohsin Shah, Daniel B. Shin, Marilyn T. Wan, Kevin L. Winthrop, Joel M. Gelfand
231 [GO] 2020―Aug―26 Comment on “Androgenetic alopecia present in the majority of patients hospitalized with COVID-19 Domen Bukovac, Urška Makše
232 [GO] 2020―Aug―26 Reply to “Comment on androgenetic alopecia present in the majority of patients hospitalized with COVID-19 Carlos G. Wambier
233 [GO] 2020―Aug―20 Strategies for Effective Medical Student Education in Dermatology During the COVID-19 Pandemic Sepideh Ashrafzadeh, Sotonye E. Imadojemu, Ruth Ann Vleugels, Elizabeth A. Buzney
234 [GO] 2020―Aug―19 Skin is a potential host of SARS-CoV-2: a clinical, single-cell transcriptome-profiling and histological study. Yangbai Sun, Renpeng Zhou, Hao Zhang, Liu Rong, Wang Zhou, Yimin Liang, Qingfeng Li
235 [GO] 2020―Aug―18 Expansion of asynchronous teledermatology during the COVID-19 pandemic Mack Y. Su, Shinjita Das
236 [GO] 2020―Aug―18 Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic Robert Stavert, Ahou Meydani-Korb, Dianne de Leon, Rebecca Osgood, Jessamyn Blau, Thien Luu
237 [GO] 2020―Aug―14 Remote Learning for Medical Student-Level Dermatology During the COVID-19 Pandemic Payal M. Patel, Cindy L. Tsui, Aakaash Varma, Jacob Levitt
238 [GO] 2020―Aug―08 COVID-19 outbreak and autoimmune bullous diseases: A systematic review of published cases Michael Kasperkiewicz
239 [GO] 2020―Aug―08 All that glisters is not COVID: low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with Chilblain-like lesions Marco Denina, Francesco Pellegrino, Francesco Morotti, Paola Coppo, Ilaria Maria Bonsignori, Silvia Garazzino, et al. (+9)
240 [GO] 2020―Aug―07 Review of adverse cutaneous reactions of pharmacologic interventions for coronavirus disease 2019 (COVID-19): a guide for the dermatologist Antonio Martinez-Lopez, Carlos Cuenca-Barrales, Trinidad Montero-Vilchez, Alejandro Molina-Leyva, Salvador Arias-Santiago
241 [GO] 2020―Jul―29 Androgenetic alopecia in COVID-19: compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign Carlos Gustavo Wambier, Sergio Vaño-Galván, John McCoy, Suraj Pai, Rachita Dhurat, Andy Goren
242 [GO] 2020―Jul―29 Androgenetic alopecia in COVID-19: Compared to what? Benjamin A. Nanes
243 [GO] 2020―Jul―28 Antecedent Immunosuppressive Therapy for Immune-Mediated Inflammatory Diseases in the Setting of a COVID-19 Outbreak Jesse Veenstra, Connor R. Buechler, Gabrielle Robinson, Stephanie Chapman, Madeline Adelman, Aaron Tisack, et al. (+4)
244 [GO] 2020―Jul―28 Assessing The Risk of Adalimumab Use For Hidradenitis Suppurativa During The COVID-19 Pandemic Donovan G. Kearns, Vipawee S. Chat, Shelley Uppal, Jashin J. Wu
245 [GO] 2020―Jul―22 Male Balding is a Major Risk Factor for Severe COVID-19. Justin Lee, Ahmed Yousaf, Wei Fang, Michael Kolodney
246 [GO] 2020―Jul―22 Hand Hygiene During COVID-19: Recommendations from the American Contact Dermatitis Society Chandler W. Rundle, Colby L. Presley, Michelle Militello, Cara Barber, Douglas L. Powell, Sharon E. Jacob, et al. (+4)
247 [GO] 2020―Jul―21 Google search increase in patient self-care during COVID-19 lockdown Tamara Searle, Firas Al-Niaimi, Faisal R. Ali
248 [GO] 2020―Jul―21 Approaching the dermatology residency application process during a pandemic Ilana S. Rosman, Courtney R. Schadt, Sara S. Samimi, Misha Rosenbach
249 [GO] 2020―Jul―16 Guiding Principles for Prioritization of Limited In-person Dermatology Appointments During the COVID-19 Pandemic Benjamin K. Stoff, Travis W. Blalock, Robert A. Swerlick, Jamie B. MacKelfresh, Leslie P. Lawley, Suephy C. Chen
250 [GO] 2020―Jul―16 Optimizing Education for Dermatology Residents During the COVID-19 Pandemic Parth Patel, Anthony K. Guzman, Beth McLellan, Rachel Blasiak
251 [GO] 2020―Jul―16 Risk assessment of outpatient dermatology practice in the setting of the Covid-19 pandemic Pedram Gerami, Walter J. Liszewski
252 [GO] 2020―Jul―16 Multidisciplinary Care of Epidermolysis Bullosa during the COVID-19 Pandemic - Consensus: Recommendations by an International Panel of Experts Dedee F. Murrell, Anne W. Lucky, Julio C. Salas-Alanis, David T. Woodley, Francis Palisson, Ken Natsuga, et al. (+38)
253 [GO] 2020―Jul―16 Prevalence of cheilitis in Health care workers managing COVID-19 patients Mehak Singh, Atul Bothra, Manoj Pawar, Anshu Maheswari, Apoorv Tiwari, Pankaj Adhicari
254 [GO] 2020―Jul―16 The digital divide: how Covid-19’s telemedicine expansion could exacerbate disparities Mina Bakhtiar, Nada Elbuluk, Jules B. Lipoff
255 [GO] 2020―Jul―16 Lack of association between chilblains outbreak and SARS-CoV-2: histological and serological findings from a new immunoassay Vivien Hébert, Anne-Bénédicte Duval-Modeste, Pascal Joly, Véronique Lemée, Lucie Cellier, Fabienne Jouen, et al. (+3)
256 [GO] 2020―Jul―15 Caution in the time of rashes and COVID-19 Matthew D. Vesely, Sara H. Perkins
257 [GO] 2020―Jul―15 Treatment discontinuation and rate of disease transmission in psoriasis patients on biologic therapy during the COVID-19 pandemic - A Canadian Multicenter Retrospective Study Jorge R. Georgakopoulos, Asfandyar Mufti, Ron Vender, Jensen Yeung
258 [GO] 2020―Jul―08 Applying to dermatology residency during the COVID-19 pandemic Donovan G. Kearns, Vipawee S. Chat, Shelley Uppal, Jashin J. Wu
259 [GO] 2020―Jul―08 Approach to VIPs during the COVID-19 pandemic and beyond Ha Eun Kong, Benjamin K. Stoff
260 [GO] 2020―Jul―08 Conducting Inpatient Dermatology Consultations and Maintaining Resident Education in the COVID-19 Telemedicine Era Margaret I. Hammond, Timmie R. Sharma, Kevin D. Cooper, Mara G. Beveridge
261 [GO] 2020―Jul―03 New insights in COVID-19-associated chilblains: a comparative study with chilblain lupus erythematosus Gilles Battesti, Jihane El Khalifa, Nour Abdelhedi, Valentine Ferre, Fabrice Bouscarat, Catherine Picard-Dahan, et al. (+16)
262 [GO] 2020―Jul―02 Risk of COVID-19 in Dermatologic Patients on Long-term Immunomodulatory Therapy Zachary E. Holcomb, Monica Rosales Santillan, Peyton C. Morss-Walton, Prerna Salian, Min Ji Her, Nicole M. Giannotti, et al. (+2)
263 [GO] 2020―Jul―02 The Risk of Respiratory Tract Infections in Psoriasis Patients Treated With IL-23-pathway Inhibiting Biologics: A Meta-Estimate of Pivotal Trials Relevant to Decision-Making During the COVID-19 Pandemic Maha N. Syed, Daniel B. Shin, Marilyn T. Wan, Kevin L. Winthrop, Joel M. Gelfand
264 [GO] 2020―Jul―02 Cling film for mobile phone to prevent cross-infection during COVID-19 pandemic Mitanjali Sethy, Vamshi Krishna, Chakravarthi R. Srinivas
265 [GO] 2020―Jul―02 The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries Esther E. Freeman, Devon E. McMahon, Jules B. Lipoff, Misha Rosenbach, Carrie Kovarik, Seemal R. Desai, et al. (+7)
266 [GO] 2020―Jun―27 Time to revisit HIPAA? Accelerated telehealth adoption during the COVID-19 pandemic Bhate, Chinmoy, Chin Hung Ho, Robert T. Brodell
267 [GO] 2020―Jun―27 Experience in patients with hidradenitis suppurativa and COVID-19 symptoms José Luis Galán Sánchez, Catiana Silvente San Nicasio, Mónica González Olivares, Claudia García Martín, Kevin Díez Madueño, María Ángeles Martín Díaz, et al. (+2)
268 [GO] 2020―Jun―27 Strategies to prevent SARS-CoV-2 transmission during dermatologic head and neck surgery Mytrang H. Do, Kira Minkis, Tatyana A. Petukhova, Shari R. Lipner
269 [GO] 2020―Jun―24 Dear Dermatoethicist: Medical Student Dermatology Rotations in the Context of COVID-19 Sonal Muzumdar, Jane M. Grant-Kels, Hao Feng
270 [GO] 2020―Jun―22 Comment on: “To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out. Characterization of herpetic lesions in hospitalized COVID-19 patients.” D. Fernandez-Nieto, D. Ortega-Quijano, A. Suarez-Valle, P. Burgos-Blasco, J. Jimenez-Cauhe, M. Fernandez-Guarino
271 [GO] 2020―Jun―19 When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection William Damsky, Danielle Peterson, Brett King
272 [GO] 2020―Jun―19 Navigating Immunosuppression in a Pandemic: A Guide for the Dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology Hospitalists Omid Zahedi Niaki, Milan J. Anadkat, Steven T. Chen, Lindy P. Fox, Joanna Harp, Robert G. Micheletti, et al. (+5)
273 [GO] 2020―Jun―17 Dear Dermatoethicist:The Ethics of Charging Patients an Infection Control Fee in the Context of COVID-19 Sonal Muzumdar, Jane M. Grant-Kels, Hao Feng
274 [GO] 2020―Jun―17 International Collaboration and Rapid Harmonization across Dermatologic COVID-19 Registries Esther E. Freeman, Devon E. McMahon, George J. Hruza, Alan D. Irvine, Phyllis I. Spuls, Catherine H. Smith, et al. (+19)
275 [GO] 2020―Jun―15 Third year Dermatology Resident Anxiety in the Era of COVID-19 Nagasai C. Adusumilli, Misty Eleryan, Shelly Tanner, Adam J. Friedman
276 [GO] 2020―Jun―15 Fighting COVID-19: Early Teledermatology Lessons Learned Jean S. McGee, Rachel V. Reynolds, Suzanne M. Olbricht
277 [GO] 2020―Jun―15 Redeployment of Dermatologists During COVID-19: Implementation of a Large-Scale, Centralized Results Management Infrastructure Nina A. Ran, Sara S. Samimi, Junqian Zhang, Krisda H. Chaiyachati, Colleen P. Mallozzi, C. William Hanson, et al. (+3)
278 [GO] 2020―Jun―14 Asynchronous teledermatology in medical education: Lessons from the COVID-19 pandemic Mack Y. Su, Evelyn Lilly, JiaDe Yu, Shinjita Das
279 [GO] 2020―Jun―10 Analysis of availability, types, and implementation of teledermatology services during COVID-19 Pavane L. Gorrepati, Gideon P. Smith
280 [GO] 2020―Jun―10 Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic Donovan G. Kearns, Shelley Uppal, Vipawee S. Chat, Jashin J. Wu
281 [GO] 2020―Jun―10 Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic Cristiana Colonna, Giovanni Genovese, Nicola Adriano Monzani, Marina Picca, Francesca Boggio, Raffaele Gianotti, Angelo Valerio Marzano
282 [GO] 2020―Jun―06 The presence and distribution of novel coronavirus in medical environment Qianli Jiang, Yinghua Chen, Yingchun Dai, Guodong Hu
283 [GO] 2020―Jun―04 Analysis of dermatology-related search engine trends during the COVID-19 pandemic: implications for patient demand for outpatient services and telehealth. Anthony K. Guzman, John S. Barbieri
284 [GO] 2020―Jun―04 Could antiphospholipid antibodies contribute to coagulopathy in COVID-19? Aurora Parodi, Giulia Gasparini, Emanuele Cozzani
285 [GO] 2020―Jun―03 Considerations for Underrepresented in Medicine Dermatology Residency Applicants Amidst the COVID-19 Pandemic Virginia A. Jones, Kayla A. Clark, Payal M. Patel, Adriana Cordova, Maria M. Tsoukas
286 [GO] 2020―Jun―02 Comment on: “Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak” D. Fernandez-Nieto, J. Jimenez-Cauhe, A. Suarez-Valle, O.M. Moreno-Arrones, D. Saceda-Corralo, A. Arana-Raja, D. Ortega-Quijano
287 [GO] 2020―Jun―02 CHILBLAIN-LIKE ACRAL LESIONS DURING THE COVID-19 PANDEMIC (“COVID TOES”): HISTOLOGIC, IMMUNOFLUORESCENCE AND IMMUNOHISTOCHEMICAL STUDY OF 17 CASES Jean Kanitakis, Cécile Lesort, Marie Danset, Denis Jullien
288 [GO] 2020―Jun―01 A Potential Hidden Reservoir: The Role of Nail Hygiene in Preventing Transmission of COVID-19 Albert G. Wu, Shari R. Lipner
289 [GO] 2020―Jun―01 Reply to: “Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak” Giuseppe Ruggiero, Fabio Arcangeli, Torello Lotti, Orsola Ametrano, Cosimo Ruggiero, Salvatore Cucchiara, Salvatore Oliva
290 [GO] 2020―Jun―01 Modifications to Dermatology Residency Education During the COVID-19 Pandemic. Asfandyar Mufti, Khalad Maliyar, Muskaan Sachdeva, Phillip Doiron
291 [GO] 2020―Jun―01 Dermatopathology Education During the COVID-19 Pandemic: Virtual Simulation of the Multi-Headed Microscope Randie H. Kim, Nooshin K. Brinster, Shane A. Meehan
292 [GO] 2020―Jun―01 Challenges and countermeasures in the prevention of nosocomial infections of SARS-CoV-2 before resumption of work: implications for the dermatology department Yamin Zhang, Jingjing Wen, Cai Chen, Lingling Zeng, Liu Yang, Changzheng Huang, et al. (+6)
293 [GO] 2020―May―30 Advances in skin science enable the development of a COVID-19 Vaccine Louis D. Falo
294 [GO] 2020―May―30 Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries Esther E. Freeman, Devon E. McMahon, Jules B. Lipoff, Misha Rosenbach, Carrie Kovarik, Junko Takeshita, et al. (+4)
295 [GO] 2020―May―22 Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acro-ischemic lesions Vincenzo Piccolo, Andrea Bassi
296 [GO] 2020―May―22 Recommendations for Medical Student Preparedness and Equity for Dermatology Residency Applications During the COVID-19 Pandemic Claire R. Stewart, Karen A. Chernoff, Horatio F. Wildman, Shari R. Lipner
297 [GO] 2020―May―22 Reply to Notes and Comments on “Proposed Approach 1 for Re-using Surgical Masks in COVID-19 Pandemic Yuangang Liu, Sancy A. Leachman, Anna Bar
298 [GO] 2020―May―22 Prescription Restrictions on Hydroxychloroquine Among the Largest Florida Pharmacy Chains During the COVID-19 Pandemic: An Observational Study Edward Hadeler, Fleta Bray
299 [GO] 2020―May―22 Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients - the “Gabrin sign” Carlos Gustavo Wambier, Sergio Vaño-Galván, John McCoy, Alba Gomez-Zubiaur, Sabina Herrera, Ángela Hermosa-Gelbard, et al. (+8)
300 [GO] 2020―May―21 Comment on: “Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acro-ischemic lesions” Fernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, Moreno-Arrones OM, Saceda-Corralo D, Arana-Raja A, Ortega-Quijano D
301 [GO] 2020―May―21 Notes and Comments on “Proposed Approach for Re-using Surgical Masks in COVID-19 Pandemic Angeli Eloise Torres, David M. Ozog, Iltefat H. Hamzavi, Henry W. Lim
302 [GO] 2020―May―20 Reply to “Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients”: To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out. Mar Llamas-Velasco, Pedro Rodríguez-Jiménez, Pablo Chicharro, Diego De Argila, Patricia Muñoz-Hernández, E. Daudén
303 [GO] 2020―May―19 Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy Vincenzo De Giorgi, Sebastiano Recalcati, Ziyi Jia, Wei Chong, Renyu Ding, Yunhua Deng, et al. (+7)
304 [GO] 2020―May―19 The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics: A meta-estimate of pivotal trials relevant to decision-making during the COVID-19 pandemic Marilyn T. Wan, Daniel B. Shin, Kevin L. Winthrop, Joel M. Gelfand
305 [GO] 2020―May―19 Hydroxychloroquine effects on psoriasis: a systematic review and a cautionary note for COVID-19 treatment Muskaan Sachdeva, Asfandyar Mufti, Khalad Maliyar, Yuliya Lytvyn, Jensen Yeung
306 [GO] 2020―May―19 Response to “Reply to ‘Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients’: To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out” Angelo Valerio Marzano, Giovanni Genovese
307 [GO] 2020―May―17 Retrospective Analysis of Smell and Taste Disturbances Associated with Dermatological Medications Reported to the United States Food and Drug Administration and Relevance to COVID-19 Infections Yu Wang, Shari R. Lipner
308 [GO] 2020―May―16 The Immediate Impact of COVID-19 on US Dermatology Practices Graham H. Litchman, Darrell S. Rigel
309 [GO] 2020―May―16 Head and neck surgery is a high-risk procedure for COVID-19 transmission and there is a need for a preventive strategy to protect professionals Ignacio Garcia-Doval
310 [GO] 2020―May―16 Cutaneous Manifestations of COVID-19: A Preliminary Review Justin L. Jia, Marija Kamceva, Saieesh A. Rao, Eleni Linos
311 [GO] 2020―May―15 COVID-19 & PPE: Treatment and Prevention of Skin Conditions Related to the Occupational Use of Personal Protective Equipment Seemal R. Desai, Carrie Kovarik, Bruce Brod, William James, Matthew E. Fitzgerald, Ave Preston, George J. Hruza
312 [GO] 2020―May―14 Algorithm for the classification of Covid-19 rashes Daniel Ortega-Quijano, Juan Jimenez-Cauhe, Gerald Selda-Enriquez, Montserrat Fernandez-Guarino, Diego Fernandez-Nieto
313 [GO] 2020―May―14 Reply to: Skin damage among healthcare workers managing coronavirus disease-2019 Khalad Maliyar, Muskaan Sachdeva, Asfandyar Mufti, Jensen Yeung
314 [GO] 2020―May―13 Optimizing Care for Atopic Dermatitis Patients During COVID-19 Pandemic Monica Shah, Muskaan Sachdeva, Afsaneh Alavi, Vivian Y. Shi, Jennifer L. Hsiao
315 [GO] 2020―May―13 Considerations for Management of Longitudinal Melanonychia During the COVID-19 Pandemic: An International Perspective Shari R. Lipner, Matilde Iorizzo, Nathaniel Jellinek, Bianca Maria Piraccini, Richard K. Scher
316 [GO] 2020―May―12 Dear Dermatoethicist: Web-Based Dermatology Residency Interviews in the Time of COVID-19 Sonal Muzumdar, Jane M. Grant-Kels, Hao Feng
317 [GO] 2020―May―12 COVID-19 and its impact on medical student education in dermatology Tiffany Y. Loh, Jennifer L. Hsiao, Vivian Y. Shi
318 [GO] 2020―May―11 Association of outdoor activity restriction and income loss with patient-reported outcomes of psoriasis during the COVID-19 pandemic: A web-based survey Yehong Kuang, Minxue Shen, Qiaolin Wang, Yi Xiao, Chengzhi Lv, Yan Luo, et al. (+2)
319 [GO] 2020―May―08 Exploring the risk of severe COVID-19 infection in hidradenitis suppurativa patients Janyla A. Seltzer, Chidubem A.V. Okeke, Jessica D. Perry, William D. Shipman, Ginette A. Okoye, Angel S. Byrd
320 [GO] 2020―May―07 Reply: A Dermatologic Manifestation of COVID-19: Transient Livedo Reticularis Iviensan F. Manalo, Molly K. Smith, Justin Cheeley, Randy Jacobs
321 [GO] 2020―May―07 Reply to: “A Dermatologic Manifestation of COVID-19: Transient Livedo Reticularis” Cristina Thomas
322 [GO] 2020―May―06 COVID-19 and biologics for psoriasis: a high-epidemic area experience - Bergamo, Lombardy, Italy Andrea Carugno, Daniele Mario Gambini, Francesca Raponi, Pamela Vezzoli, Andrea Gustavo C. Locatelli, Marco Di Mercurio, et al. (+2)
323 [GO] 2020―May―06 Perspectives on the Recommendations for Skin Cancer Management During the COVID-19 Pandemic Larisa J. Geskin, Megan H. Trager, Sumaira Z. Aasi, David R. Bickers, Richard D. Carvajal, Paul Nghiem, et al. (+3)
324 [GO] 2020―May―04 The COVID-19 crisis: A unique opportunity to expand dermatology to underserved populations Sepideh Ashrafzadeh, Vinod E. Nambudiri
325 [GO] 2020―May―04 Invited Commentary on the letter "The COVID-19 crisis: A unique opportunity to expand dermatology to underserved populations." Carrie Kovarik, Ivy Lee, Trilokraj Tejasvi, Jules B. Lipoff
326 [GO] 2020―May―04 Clinical considerations for managing dermatology patients on systemic immunosuppressive and/or biologic therapy during COVID-19 pandemic Daniela P. Sanchez, Robert S. Kirsner, Hadar Lev-Tov
327 [GO] 2020―May―04 Cyclosporine therapy during the COVID-19 pandemic is not a reason for concern. Lidia Rudnicka, Mohamad Goldust, Paulina Glowacka, Mariusz Sikora, Marta Sar-Pomian, Adriana Rakowska, et al. (+2)
328 [GO] 2020―May―04 Chilblains are a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France Adèle de Masson, Jean-David Bouaziz, Luc Sulimovic, Charles Cassius, Marie Jachiet, Marius-Anton Ionescu, et al. (+3)
329 [GO] 2020―May―04 Reply to “Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients”: discussing specificity Daniel Ortega-Quijano, Juan Jimenez-Cauhe, Patricia Burgos-Blasco, Natalia Jimenez-Gomez, Diego Fernandez-Nieto
330 [GO] 2020―May―01 Hidradenitis suppurativa: the importance of virtual outpatient care during COVID-19 pandemic Monica Shah, Haley B. Naik, Raed Alhusayen
331 [GO] 2020―May―01 COVID-19:Should sexual practices be discouraged during the pandemic? ZhiQiang Yin
332 [GO] 2020―May―01 Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatological and rheumatological patients already under treatment. Maria Vastarella, Angela Patrì, Maria Carmela Annunziata, Mariateresa Cantelli, Paola Nappa, Marco Tasso, et al. (+3)
333 [GO] 2020―Apr―27 Calm before the storm: understanding the role of JAK inhibitors in COVID-19 Danielle Peterson, William Damsky, Brett King
334 [GO] 2020―Apr―27 Proposed approach for reusing surgical masks in COVID-19 pandemic Yuangang Liu, Sancy Leachman, Anna Bar
335 [GO] 2020―Apr―27 What matters most: Why the COVID-19 pandemic should prompt us to revisit the dermatology resident selection process Daniel Karasik, Daniel M. O’Connor, Neera R. Nathan
336 [GO] 2020―Apr―27 Risks of Hydroxychloroquine use for COVID-19 prophylaxis Muskaan Sachdeva, Monica Shah, Michael Ziv, Eyal Leshem, Roni P. Dodiuk-Gad
337 [GO] 2020―Apr―27 Response to “Risks of Hydroxychloroquine use for COVID-19 prophylaxis” Jane M. Grant-Kels
338 [GO] 2020―Apr―27 Reply to: Personal Protective Equipment Recommendations Based on COVID-19 Route of Transmission Gregory Cavanagh, Carlos Wambier
339 [GO] 2020―Apr―24 Potential role of Janus kinase inhibitors in COVID-19 Maddalena Napolitano, Gabriella Fabbrocini, Cataldo Patruno
340 [GO] 2020―Apr―24 Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak D. Fernandez-Nieto, J. Jimenez-Cauhe, A. Suarez-Valle, O.M. Moreno-Arrones, D. Saceda-Corralo, A. Arana-Raja, D. Ortega-Quijano
341 [GO] 2020―Apr―24 Recommendations for phototherapy during the COVID-19 pandemic Henry W. Lim, Steven R. Feldman, Abby S. Van Voorhees, Joel M. Gelfand
342 [GO] 2020―Apr―24 Telemedicine for Inpatient Dermatology Consultations in Response to the COVID-19 Pandemic John Trinidad, Daniela Kroshinksy, Benjamin H. Kaffenberger, Nathan Rojek
343 [GO] 2020―Apr―24 Cutaneous manifestations in COVID-19: Lessons learned from current evidence Poonkiat Suchonwanit, Kanchana Leerunyakul, Chaninan Kositkuljorn
344 [GO] 2020―Apr―22 Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biological treatment and renal transplanted recipients in maintenance immunosuppressive treatment Paolo Gisondi, Gianluigi Zaza, Micol Del Giglio, Mattia Rossi, Valentina Iacono, Giampiero Girolomoni
345 [GO] 2020―Apr―22 Teledermatology in the Wake of COVID-19: Advantages and Challenges to Continued Care in a Time of Disarray Rohit Gupta, Marina K. Ibraheim, Hung Q. Doan
346 [GO] 2020―Apr―21 Invited response to the comment on “Dermatology Residents and the Care of COVID-19 Patients” Jane M. Grant-Kels
347 [GO] 2020―Apr―21 Comment on “Dermatology Residents and the Care of COVID-19 Patients” Basil Patel
348 [GO] 2020―Apr―21 Personal Protective Equipment Recommendations Based on COVID-19 Route of Transmission Mohit Kumar Gupta, Shari R. Lipner
349 [GO] 2020―Apr―17 The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19 Esther E. Freeman, Devon E. McMahon, Matthew E. Fitzgerald, Lindy P. Fox, Misha Rosenbach, Junko Takeshita, et al. (+3)
350 [GO] 2020―Apr―17 COVID-19 and Racial Disparities Monica Shah, Muskaan Sachdeva, Roni P. Dodiuk-Gad
351 [GO] 2020―Apr―17 Teledermatology in the Era of COVID-19: Experience of an Academic Department of Dermatology Sara Perkins, Jeffrey M. Cohen, Caroline A. Nelson, Christopher G. Bunick
352 [GO] 2020―Apr―16 Letter from the Editors: Big Data and Cutaneous Manifestations of COVID-19 Jane M. Grant-Kels, Brett Sloan, Jonathan Kantor, Dirk M. Elston
353 [GO] 2020―Apr―16 United States Cutaneous Lymphoma Consortium Recommendations for Treatment of Cutaneous Lymphomas During the COVID-19 Pandemic J.A. Zic, W. Ai, O.E. Akilov, J.B. Carter, M. Duvic, F. Foss, et al. (+9)
354 [GO] 2020―Apr―16 Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients Angelo Valerio Marzano, Giovanni Genovese, Gabriella Fabbrocini, Paolo Pigatto, Giuseppe Monfrecola, Bianca Maria Piraccini, et al. (+7)
355 [GO] 2020―Apr―16 Overzealous hand hygiene during COVID 19 pandemic causing increased incidence of hand eczema among general population Mehak Singh, Manoj Pawar, Atul Bothra, Nishant Choudhary
356 [GO] 2020―Apr―10 Back to the Basics: Diluted Bleach for COVID-19 Parth Patel, Sanjna Sanghvi, Kunal Malik, Amor Khachemoune
357 [GO] 2020―Apr―10 Various forms of skin rash in COVID-19 : a reply Beuy Joob, Viroj Wiwanitkit
358 [GO] 2020―Apr―10 Hydroxychloroquine and ivermectin: a synergistic combination for COVID-19 chemoprophylaxis and/or treatment? Angela Patrì, Gabriella Fabbrocini
359 [GO] 2020―Apr―10 Reply to “COVID-19 can present with a rash and be mistaken for Dengue”: Petechial rash in a patient with COVID-19 infection Juan Jimenez-Cauhe, Daniel Ortega-Quijano, Marta Prieto-Barrios, Oscar M. Moreno-Arrones, Diego Fernandez-Nieto
360 [GO] 2020―Apr―10 Biologics for psoriasis during COVID-19 outbreak Vito Di Lernia
361 [GO] 2020―Apr―10 Reply to: “Biologics for psoriasis during COVID-19 outbreak” Dedee F. Murrell, Ryan Rivera-Oyola, Mark Lebwohl
362 [GO] 2020―Apr―10 Recommendations on dermatologic surgery during the COVID-19 pandemic Samuel Antranig Der Sarkissian, Leo Kim, Michael Veness, Eleni Yiasemides, Deshan Frank Sebaratnam
363 [GO] 2020―Apr―10 Optimizing Teledermatology Visits for Dermatology Resident Education During the COVID-19 Pandemic Reid Oldenburg, Amanda Marsch
364 [GO] 2020―Apr―10 Treatment considerations for patients with pemphigus during the COVID-19 pandemic Hadir Shakshouk, Maryam Daneshpazhooh, Dedee F. Murrell, Julia S. Lehman
365 [GO] 2020―Apr―10 Adalimumab for Treatment of Hidradenitis Suppurativa During the COVID-19 Pandemic: Safety Considerations Alecia Blaszczak, John C.L. Trinidad, Alexander M. Cartron
366 [GO] 2020―Apr―10 Creating Dermatology Guidelines for Covid-19: The Pitfalls of Applying Evidence Based Medicine to an Emerging Infectious Disease Esther E. Freeman, Devon E. McMahon
367 [GO] 2020―Apr―10 A Dermatologic Manifestation of COVID-19: Transient Livedo Reticularis Iviensan F. Manalo, Molly K. Smith, Justin Cheeley, Randy Jacobs
368 [GO] 2020―Apr―10 Does Hydroxychloroquine Combat COVID-19? A Timeline of Evidence Erisa Alia, Jane M. Grant-Kels
369 [GO] 2020―Apr―10 Reply to: “Skin damage among healthcare workers managing coronavirus disease-2019” Teresa Oranges, Agata Janowska, Valentina Dini
370 [GO] 2020―Apr―10 SARS-COV-2 infection is likely to be androgen mediated Carlos Gustavo Wambier, Andy Goren
371 [GO] 2020―Apr―10 Sexual transmission of SARS-CoV-2: a new possible route of infection? Angela Patrì, Lucia Gallo, Maria Guarino, Gabriella Fabbrocini
372 [GO] 2020―Apr―09 The use of Janus kinase inhibitors in the time of SARS-CoV-2 Danielle Peterson, William Damsky, Brett King
373 [GO] 2020―Apr―08 Strategic Dermatology Clinical Operations During COVID-19 Pandemic Kyla N. Price, Rebecca Thiede, Vivian Y. Shi, Clara Curiel-Lewandrowski
374 [GO] 2020―Apr―05 Rational hand hygiene during COVID-19 pandemic Gregory Cavanagh, Carlos Wambier
375 [GO] 2020―Apr―04 Dermatology Residents and the Care of COVID-19 Patients Victoria J. Stoj, Jane M. Grant-Kels
376 [GO] 2020―Apr―01 Ultraviolet germicidal irradiation: possible method for respirator disinfection to facilitate reuse during COVID-19 pandemic Iltefat H. Hamzavi, Alexis B. Lyons, Indermeet Kohli, Shanthi Narla, Angela Parks-Miller, Joel M. Gelfand, et al. (+2)
377 [GO] 2020―Apr―01 COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution Naveen Kumar Kansal
378 [GO] 2020―Mar―31 Use of Systemic Immunomodulatory Therapies During the Coronavirus Disease 2019 (COVID-19) Pandemic Payal Shah, John G. Zampella
379 [GO] 2020―Mar―31 Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment Alessia Villani, Gabriella Fabbrocini, Claudia Costa, Massimiliano Scalvenzi
380 [GO] 2020―Mar―28 Telehealth: Helping Your Patients and Practice Survive and Thrive During the COVID-19 Crisis with Rapid Quality Implementation Ivy Lee, Carrie Kovarik, Trilokraj Tejasvi, Michelle Pizarro, Jules B. Lipoff
381 [GO] 2020―Mar―26 COVID-19 and Immunomodulator/Immunosuppressant Use in Dermatology Kyla N. Price, John W. Frew, Jennifer L. Hsiao, Vivian Y. Shi
382 [GO] 2020―Mar―26 Ethical Outpatient Dermatology Care During the Coronavirus (COVID-19) Pandemic James T. Pathoulas, Benjamin K. Stoff, Kachiu C. Lee, Ronda S. Farah
383 [GO] 2020―Mar―22 COVID-19 can present with a rash and be mistaken for Dengue Beuy joob, Viroj Wiwanitkit
384 [GO] 2020―Mar―22 Dermatology practices as vectors for COVID-19 transmission: a call for immediate cessation of non-emergent dermatolgy visits Shawn G. Kwatra, Ronald J. Sweren, Anna L. Grossberg
385 [GO] 2020―Mar―19 Should biologics for psoriasis be interrupted in the era of COVID-19? Mark Lebwohl, Ryan Rivera-Oyola, Dedee F. Murrell
386 [GO] 2020―Mar―18 Letter from the Editor: Occupational skin disease among healthcare workers during the Coronavirus (COVID-19) epidemic Dirk M. Elston
387 [GO] 2020―Mar―18 Behavioral considerations and impact on personal protective equipment (PPE) use: Early lessons from the coronavirus (COVID-19) outbreak Jonathan Kantor
388 [GO] 2020―Mar―18 Skin damage among healthcare workers managing coronavirus disease-2019 Jiajia Lan, Zexing Song, Xiaoping Miao, Hang Li, Yan Li, Liyun Dong, et al. (+10)
389 [GO] 2020―Feb―17 What are we doing in the dermatology outpatient department amidst the raging of 2019-nCoV? Yusha Chen, Sushmita Pradhan, Siliang Xue
 [1] 

389 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.022 sec